ERS International Congress 2016 DETAILED PROGRAMME TUESDAY 06 SEPTEMBER, 2016 OA3317 OA3318 OA3319 OA3320 OA3321 Association of living in a farming environment with asthma incidence in Canadian children Ambikiapakan Senthilselvan (Edmonton, AB, Canada), Marc Parsons, Jeremy Beach, Ambikiapakan Senthilselvan Adverse pregnancy outcomes and familial confounding in asthmatic women – A population based family design study Gustaf Rejnö (Vällingby, Sweden), Gustaf Rejnö, Cecilia Lundholm, Kjell Larsson, Henrik Larsson, Paul Lichtenstein, Brian M. D’Onofrio, Sissel Saltvedt, Catarina Almqvist Dampness and mould on respiratory health – A longitudinal approach. Results from the MeDALL study Christina Tischer (Barcelona, Spain), Christina Tischer, Carla Tiesler, Marie Standl, Ulrike Gehring, Alet Wijga, Erik Melen, Jesse Thacher, Maties Torrent, Jordi Sunyer, Thomas Keil, Isabella Annesi-Maesano, Josep M. Anto, Joachim Heinrich Atopy as a predictor of allergic respiratory diseases in an Italian general population sample Sandra Baldacci (Pisa, PI, Italy), Sandra Baldacci, Sara Maio, Anna Angino, Sonia Cerrai, Giuseppe Sarno, Franca Martini, Francesco Di Pede, Francesco Pistelli, Laura Carrozzi, Giovanni Viegi Age at allergic sensitization is strongly related to asthma and rhinitis in young adulthood Joakim Bunne (Piteå, Sweden), Joakim Bunne, Linnea Hedman, Martin Andersson, Helena Backman, Bo Lundbäck, Eva Rönmark OA3322 Influence of gene-by-early environmental tobacco smoke exposure interactions on time-to-asthma onset Chloé SARNOWSKI (PARIS, France), Chloé Sarnowski, Marie-Hélène Dizier, Raquel Granell, Debbie Jarvis, Markus J. Ege, Catherine Laprise, Pierre-Emmanuel Sugier, Patricia Margaritte-Jeannin, William Cookson, Miriam Moffatt, Mark Lathrop, Isabelle Pin, Erika Von Mutius, Valérie Siroux, John Henderson, Manolis Kogevinas, Florence Demenais, Emmanuelle Bouzigon Room M Session 529 08:30 - 10:30 Oral Presentation: Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Chairs : Antoni Torres Marti (Barcelona, Spain), Eva Van Braeckel (Ghent, Belgium) OA3323 LATE-BREAKING ABSTRACT: Intravenous infusion of Chinese medicine xuebijing significantly improved clinical outcome in severe pneumonia patients in a multiple center randomized controlled clinical trials Yuanlin Song (Shanghai, China), Yuanlin Song, Chen Yao, Hongcai Shang, Xiaoqing Yao, Chunxue Bai OA3324 OA3325 OA3326 OA3327 OA3328 OA3329 Do school holidays affect adult pneumococcal community acquired pneumonia incidence? Priya Daniel (nottingham, United Kingdom), Priya Daniel, Chamira Rodrigo, Thomas Bewick, Sonia Greenwood, Tricia McKeever, Carmen Sheppard, Mary Slack, Wei Shen Lim Cardiac troponin T in predicting mortality after hospitalisation for community-acquired pneumonia Stefan Vestjens (Nieuwegein, Netherlands), Stefan Vestjens, Simone Spoorenberg, Ger Rijkers, Jan Grutters, Jurriën Ten Berg, Ewoudt van de Garde, Willem Jan Bos Biomarkers and cardiovascular events in community-acquired pneumonia Raúl Méndez (VALENCIA, Spain), Raúl Méndez, Irene Aldás, Isabel Amara-Elori, Alexandra Gimeno, Tomás Posadas, Soledad Reyes, Marta Suescun, Ricardo Alonso, Rosario Menéndez Survival benefit of beta-lactam plus macrolide combined therapy versus beta-lactam plus quinolones in hospitalized community-acquired pneumonia Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain), Francisco Sanz Herrero, Estrella Fernández-Fabrellas, Eusebi Chiner, María Luisa Briones, Ruben Lera, María Carmen Aguar, Ángela Cervera, José Blanquer Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia Adrian Ceccato (Ituzaingo, Argentina), Adrian Ceccato, Miquel Ferrer, Albert Gabarrus, Oriol Sibilla, Eva Polverino, Catia Cilloniz, Carlos Agusti, Francisca Lopez, Michael Niederman, Antoni Torres Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia Eric Mortensen (Dallas, United States of America), Eric Mortensen, Antonio Anzueto OA3330 Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia : A cohort study Damien Basille (Amiens, France), Damien Basille, Charlotte Trouve, Nathalie Plouvier, Claire Andrejak, Vincent Jounieaux Room P Session 530 08:30 - 10:30 Oral Presentation: Lung allograft dysfunction: insights into inflammatory/immune mechanisms Chairs : Bart Vanaudenaerde (LEUVEN, Belgium), Andrew Fisher (Newcastle, United Kingdom) 222 26.08.2016
ERS International Congress 2016 DETAILED PROGRAMME TUESDAY 06 SEPTEMBER, 2016 OA3331 OA3332 OA3333 OA3334 OA3335 OA3336 OA3337 LATE-BREAKING ABSTRACT: Long-term consequences of central airways stenosis after lung transplantation Michele Porzio (Strasbourg, France), Michele Porzio, Andrea Mazzetta, Romain Kessler, Anne Olland The influence of extracorporeal photopheresis on NF B signaling and cytokine expression in lung transplant patients Linda Langehegermann (Essen, Germany), Linda Langehegermann, Ilona Spyra, Vasiliki Besa, Björn E. Kleibrink, Gerhard Weinreich, Helmut Teschler, Uwe Hillen, Bastian Schilling, Cindy Franklin, Sabine Meyer, Esra Alabas, Markus Kamler, Peter A. Horn, Vera Rebmann, Urte Sommerwerck Inflammatory response following DCD and DBD lung transplantation Rosalba Romano (Harefield, United Kingdom), Rosalba Romano, Louit Thakuria, Shirin Sheibani, Fabio De Robertis, Aron-Frederik Popov, Mohamed Amrani, Toufan Bahrami, Paras Dalal, Simona Soresi, Martin Carby, Anna Reed, Andre Simon, Nandor Marczin, Harefield POPSTAR Group Intra tracheal instillation of BMSC-cm attenuate acute rejection in rat lung allotransplantation Jaroslaw Pierog (Szczecin, Poland), Jaroslaw Pierog, Luca Tamo, Gregor Kocher, Richard Fakin, Mathias Gugger, Tomasz Grodzki, Thomas Geiser, Amiq Gazdhar, Ralph Alexander Schmid Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles Benjamin Renaud-Picard (STRASBOURG, France), Benjamin Renaud-Picard, Justine Toussaint, Fatiha El Ghazouani, Florence Toti, Laurence Kessler, Romain Kessler Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Domenica Federica Briganti (Borgarello, Italy), Domenica Federica Briganti, Beatrice Aramini, Carla Kim, Robin Chan, Bowen Zhou, Somwmya Sreekanth, Kashif Raza, Hilary Robbins, Lori Shah, Selim Arcasoy, Joshua Sonett, Federica Meloni, Gilbert Di Paolo, Frank D’Ovidio A post-hoc analysis of donor lungs declined for transplantation Stijn Verleden (Leuven, Belgium), Stijn Verleden, An Martens, Tobias Heigl, Hannelore Bellon, Elly Vandermeulen, Robin Vos, Johny Verschakelen, Walter Coudyzer, Dirk Van Raemdonck, Arne Neyrinck, Bart Vanaudenaerde OA3338 Long-term kinetics of CD19+CD24 high CD38 high Breg cells in lung transplant recipients Davide Piloni (PAVIA, Italy), Davide Piloni, Monica Morosini, Sara Magni, Alice Balderacchi, Emanuela Cova, Simona Inghilleri, Andrea Maria D’Armini, Luigia Scudeller, Filippo Antonacci, Tiberio Oggionni, Federica Meloni Room K Session 531 08:30 - 10:30 Oral Presentation: Therapeutic trials in lung cancer Chairs : Jacques Cadranel (Paris, France), Achim Rittmeyer (Immenhausen, Germany) OA6010 Introduction: The role of the respiratory physician in therapeutic trials in lung cancer Achim Rittmeyer (Immenhausen, Germany) OA3339 OA3340 OA3341 OA3342 OA3343 OA3344 Co-expression of S100A14 and S100A16 is a predictive marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinomas KEN KATONO (KANAGAWA, Japan), Ken Katono, Yuichi Sato, Shinichiro Ryuge, Ryo Nagashio, Masanori Yokoba, Masato Katagiri, Kazu Shiomi, Yukitoshi Satoh, Noriyuki Masuda 24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced nonsquamous non-small cell lung cancer (NSCLC) Florent Baty (St. Gallen, Switzerland), Florent Baty, Martin Früh, Markus Jörger, Martin Brutsche Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma Chai Chee Shee (Petaling Jaya, Malaysia), Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang Afatinib (A) vs gefitinib (G) as first-line treatment (tx) for patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: LUX-Lung 7 Vera Hirsh (Montréal, QC, Canada), Vera Hirsh, Keunchil Park, Eng-Huat Tan, Li Zhang, Kenneth O’Byrne, Michael Boyer, James Chih-Hsin Yang, Tony Mok, Jean Fan, Dan Massey, Luis Paz-Ares A case series of eight patients treated with alectinib including a case of interstitial lung disease Yoshihiko Sakata (Kumamoto, Japan), Yoshihiko Sakata, Kodai Kawamura, Yuko Yasuda, Naoki Shingu, Keisuke Anan, Kazuya Ichikado A phase II trial of lipoplatin and gemcitabine in patients with NSCLC previously treated with platinum-based chemotherapy Marios E. Froudarakis (Alexandroupolis, Greece), Konstantinos Kaltsas, Stavros Anevlavis, Athanasia Pataka, Georgios Kouliatsis, Sofia Pozova, Demosthenes Bouros, Marios Froudarakis 223 26.08.2016
- Page 1:
HELP SHAPE THE FUTURE OF RESPIRATOR
- Page 4 and 5:
WELCOME FROM THE CONGRESS CHAIRS ER
- Page 6 and 7:
ERS LONDON 2016 Data scanning syste
- Page 8 and 9:
MAPS ERS LONDON 2016 ■ CONGRESS M
- Page 10 and 11:
MAPS ERS LONDON 2016 ■ EXHIBITION
- Page 12 and 13:
ERS MAPSWORLD VILLAGE ERS LONDON 20
- Page 14 and 15:
INVITATION JOIN US AT THE OPENING C
- Page 16 and 17:
CONGRESS RESOURCES AREA Te Congress
- Page 18 and 19:
ERS-SPLF Joint Session Saturday 3 S
- Page 20 and 21:
ERS-CTS Joint Session Saturday 3 Se
- Page 22 and 23:
PROGRAMME AT A GLANCE
- Page 24 and 25:
ERS International Congress 2016 OUT
- Page 26 and 27:
ERS International Congress 2016 OUT
- Page 28 and 29:
ERS International Congress 2016 OUT
- Page 30 and 31:
ERS International Congress 2016 OUT
- Page 32 and 33:
ERS International Congress 2016 OUT
- Page 34 and 35:
ERS International Congress 2016 OUT
- Page 36 and 37:
ERS International Congress 2016 OUT
- Page 38 and 39:
ERS International Congress 2016 OUT
- Page 40 and 41:
ERS International Congress 2016 OUT
- Page 42 and 43:
WORLD VILLAGE SESSIONS
- Page 44 and 45:
PROGRAMME DETAILS
- Page 46 and 47:
ERS International Congress 2016 DET
- Page 48 and 49:
ERS International Congress 2016 DET
- Page 50 and 51:
ERS International Congress 2016 DET
- Page 52 and 53:
ERS International Congress 2016 DET
- Page 54 and 55:
ERS International Congress 2016 Roo
- Page 56 and 57:
ERS International Congress 2016 DET
- Page 58 and 59:
ERS International Congress 2016 DET
- Page 60 and 61:
ERS International Congress 2016 DET
- Page 62 and 63:
ERS International Congress 2016 DET
- Page 64 and 65:
ERS International Congress 2016 Roo
- Page 66 and 67:
ERS International Congress 2016 Roo
- Page 68 and 69:
ERS International Congress 2016 DET
- Page 70 and 71:
ERS International Congress 2016 Roo
- Page 72 and 73:
ERS International Congress 2016 DET
- Page 74 and 75:
ERS International Congress 2016 DET
- Page 76 and 77:
ERS International Congress 2016 DET
- Page 78 and 79:
ERS International Congress 2016 DET
- Page 80 and 81:
ERS International Congress 2016 DET
- Page 82 and 83:
ERS International Congress 2016 DET
- Page 84 and 85:
ERS International Congress 2016 DET
- Page 86 and 87:
ERS International Congress 2016 DET
- Page 88 and 89:
ERS International Congress 2016 DET
- Page 90 and 91:
ERS International Congress 2016 DET
- Page 92 and 93:
ERS International Congress 2016 DET
- Page 94 and 95:
ERS International Congress 2016 DET
- Page 96 and 97:
ERS International Congress 2016 T-0
- Page 98 and 99:
ERS International Congress 2016 DET
- Page 100 and 101:
ERS International Congress 2016 DET
- Page 102 and 103:
ERS International Congress 2016 DET
- Page 104 and 105:
ERS International Congress 2016 DET
- Page 106 and 107:
ERS International Congress 2016 T-1
- Page 108 and 109:
ERS International Congress 2016 DET
- Page 110 and 111:
ERS International Congress 2016 DET
- Page 112 and 113:
ERS International Congress 2016 DET
- Page 114 and 115:
ERS International Congress 2016 DET
- Page 116 and 117:
ERS International Congress 2016 DET
- Page 118 and 119:
ERS International Congress 2016 DET
- Page 120 and 121:
ERS International Congress 2016 DET
- Page 122 and 123:
ERS International Congress 2016 DET
- Page 124 and 125:
ERS International Congress 2016 DET
- Page 126 and 127:
ERS International Congress 2016 DET
- Page 128 and 129:
ERS International Congress 2016 DET
- Page 130 and 131:
ERS International Congress 2016 DET
- Page 132 and 133:
ERS International Congress 2016 DET
- Page 134 and 135:
ERS International Congress 2016 DET
- Page 136 and 137:
ERS International Congress 2016 DET
- Page 138 and 139:
ERS International Congress 2016 DET
- Page 140 and 141:
ERS International Congress 2016 DET
- Page 142 and 143:
ERS International Congress 2016 DET
- Page 144 and 145:
ERS International Congress 2016 Pla
- Page 146 and 147:
ERS International Congress 2016 DET
- Page 148 and 149:
ERS International Congress 2016 Roo
- Page 150 and 151:
ERS International Congress 2016 DET
- Page 152 and 153:
ERS International Congress 2016 DET
- Page 154 and 155:
ERS International Congress 2016 DET
- Page 156 and 157:
ERS International Congress 2016 DET
- Page 158 and 159:
ERS International Congress 2016 DET
- Page 160 and 161:
ERS International Congress 2016 Roo
- Page 162 and 163:
ERS International Congress 2016 DET
- Page 164 and 165:
ERS International Congress 2016 DET
- Page 166 and 167:
ERS International Congress 2016 ICC
- Page 168 and 169:
ERS International Congress 2016 DET
- Page 170 and 171:
ERS International Congress 2016 DET
- Page 172 and 173:
ERS International Congress 2016 DET
- Page 174 and 175:
ERS International Congress 2016 DET
- Page 176 and 177:
ERS International Congress 2016 DET
- Page 178 and 179:
ERS International Congress 2016 DET
- Page 180 and 181:
ERS International Congress 2016 DET
- Page 182 and 183:
ERS International Congress 2016 Pla
- Page 184 and 185:
ERS International Congress 2016 Roo
- Page 186 and 187:
ERS International Congress 2016 DET
- Page 188 and 189:
ERS International Congress 2016 DET
- Page 190 and 191:
ERS International Congress 2016 DET
- Page 192 and 193:
ERS International Congress 2016 DET
- Page 194 and 195:
ERS International Congress 2016 DET
- Page 196 and 197:
ERS International Congress 2016 DET
- Page 198 and 199:
ERS International Congress 2016 DET
- Page 200 and 201:
ERS International Congress 2016 DET
- Page 202 and 203:
ERS International Congress 2016 DET
- Page 204 and 205:
ERS International Congress 2016 DET
- Page 206 and 207:
ERS International Congress 2016 DET
- Page 208 and 209:
ERS International Congress 2016 DET
- Page 210 and 211:
ERS International Congress 2016 DET
- Page 212 and 213:
ERS International Congress 2016 DET
- Page 214 and 215:
ERS International Congress 2016 DET
- Page 216 and 217: ERS International Congress 2016 DET
- Page 218 and 219: ERS International Congress 2016 DET
- Page 220 and 221: ERS International Congress 2016 DET
- Page 222 and 223: ERS International Congress 2016 DET
- Page 224 and 225: ERS International Congress 2016 DET
- Page 226 and 227: ERS International Congress 2016 DET
- Page 228 and 229: ERS International Congress 2016 DET
- Page 230 and 231: ERS International Congress 2016 DET
- Page 232 and 233: ERS International Congress 2016 DET
- Page 234 and 235: ERS International Congress 2016 DET
- Page 236 and 237: ERS International Congress 2016 DET
- Page 238 and 239: ERS International Congress 2016 DET
- Page 240 and 241: ERS International Congress 2016 DET
- Page 242 and 243: ERS International Congress 2016 DET
- Page 244 and 245: ERS International Congress 2016 DET
- Page 246 and 247: ERS International Congress 2016 Roo
- Page 248 and 249: ERS International Congress 2016 DET
- Page 250 and 251: ERS International Congress 2016 DET
- Page 252 and 253: ERS International Congress 2016 DET
- Page 254 and 255: ERS International Congress 2016 DET
- Page 256 and 257: ERS International Congress 2016 Roo
- Page 258 and 259: ERS International Congress 2016 DET
- Page 260 and 261: ERS International Congress 2016 DET
- Page 262 and 263: ERS International Congress 2016 DET
- Page 264 and 265: ERS International Congress 2016 Pla
- Page 268 and 269: ERS International Congress 2016 DET
- Page 270 and 271: ERS International Congress 2016 DET
- Page 272 and 273: ERS International Congress 2016 DET
- Page 274 and 275: ERS International Congress 2016 DET
- Page 276 and 277: ERS International Congress 2016 DET
- Page 278 and 279: ERS International Congress 2016 DET
- Page 280 and 281: ERS International Congress 2016 DET
- Page 282 and 283: ERS International Congress 2016 DET
- Page 284 and 285: ERS International Congress 2016 DET
- Page 286 and 287: ERS International Congress 2016 DET
- Page 288 and 289: ERS International Congress 2016 DET
- Page 290 and 291: ERS International Congress 2016 DET
- Page 292 and 293: ERS International Congress 2016 DET
- Page 294 and 295: ERS International Congress 2016 DET
- Page 296 and 297: ERS International Congress 2016 DET
- Page 298 and 299: ERS International Congress 2016 DET
- Page 300 and 301: ERS International Congress 2016 T-1
- Page 302 and 303: ERS International Congress 2016 DET
- Page 304 and 305: ERS International Congress 2016 DET
- Page 306 and 307: ERS International Congress 2016 DET
- Page 308 and 309: ERS International Congress 2016 DET
- Page 310 and 311: ERS International Congress 2016 DET
- Page 312 and 313: ERS International Congress 2016 DET
- Page 314 and 315: ERS International Congress 2016 DET
- Page 316 and 317:
ERS International Congress 2016 DET
- Page 318 and 319:
ERS International Congress 2016 DET
- Page 320 and 321:
ERS International Congress 2016 DET
- Page 322 and 323:
ERS International Congress 2016 DET
- Page 324 and 325:
ERS International Congress 2016 DET
- Page 326 and 327:
ERS International Congress 2016 DET
- Page 328 and 329:
ERS International Congress 2016 DET
- Page 330 and 331:
ERS International Congress 2016 DET
- Page 332 and 333:
ERS International Congress 2016 DET
- Page 334 and 335:
ERS International Congress 2016 DET
- Page 336 and 337:
ERS International Congress 2016 DET
- Page 338 and 339:
ERS International Congress 2016 13:
- Page 340 and 341:
ERS International Congress 2016 DET
- Page 342 and 343:
ERS International Congress 2016 DET
- Page 344 and 345:
ERS International Congress 2016 DET
- Page 346 and 347:
ERS International Congress 2016 DET
- Page 348 and 349:
ERS International Congress 2016 DET
- Page 350 and 351:
ERS International Congress 2016 DET
- Page 352 and 353:
ERS International Congress 2016 DET
- Page 354 and 355:
ERS International Congress 2016 Pla
- Page 356 and 357:
ERS International Congress 2016 DET
- Page 358 and 359:
ERS International Congress 2016 DET
- Page 360 and 361:
ERS International Congress 2016 DET
- Page 362 and 363:
ERS International Congress 2016 DET
- Page 364 and 365:
ERS International Congress 2016 DET
- Page 366 and 367:
ERS International Congress 2016 DET
- Page 368 and 369:
ERS International Congress 2016 DET
- Page 370 and 371:
ERS International Congress 2016 DET
- Page 372 and 373:
ERS International Congress 2016 DET
- Page 374 and 375:
ERS International Congress 2016 DET
- Page 376 and 377:
ERS International Congress 2016 DET
- Page 378 and 379:
ERS International Congress 2016 WOR
- Page 380 and 381:
ERS International Congress 2016 WOR
- Page 382 and 383:
ERS International Congress 2016 WOR
- Page 384 and 385:
ERS International Congress 2016 IND
- Page 386 and 387:
ERS International Congress 2016 IND
- Page 388 and 389:
INDUSTRY SPONSORED SESSIONS DISCLAI
- Page 390 and 391:
ERS International Congress 2016 IND
- Page 392 and 393:
ERS International Congress 2016 IND
- Page 394 and 395:
ERS International Congress 2016 IND
- Page 396 and 397:
ERS International Congress 2016 IND
- Page 398 and 399:
ERS International Congress 2016 IND
- Page 400 and 401:
ERS International Congress 2016 IND
- Page 402 and 403:
ERS International Congress 2016 IND
- Page 404 and 405:
ERS International Congress 2016 IND
- Page 406 and 407:
ERS International Congress 2016 IND
- Page 408 and 409:
CHAIR AND COORDINATOR INDEX Name, S
- Page 410 and 411:
CHAIR AND COORDINATOR INDEX S., 456
- Page 412 and 413:
SPEAKER INDEX 4753, 4758, 4759 GIBS
- Page 414 and 415:
SPEAKER INDEX ZAR H., 1734 ZAVORSKY
- Page 416 and 417:
AUTHOR INDEX AKHTER S., PA1020, 118
- Page 418 and 419:
AUTHOR INDEX ARAUJO SILVA C., PA136
- Page 420 and 421:
AUTHOR INDEX 4323, 4866, 4869 BARBA
- Page 422 and 423:
AUTHOR INDEX BILTON D., PA2633, PA4
- Page 424 and 425:
AUTHOR INDEX BROWN M., PA5047 BROWN
- Page 426 and 427:
AUTHOR INDEX PA2759 CASTIGLIA D., P
- Page 428 and 429:
AUTHOR INDEX ALVAREZ B., PA1034 CIM
- Page 430 and 431:
AUTHOR INDEX D’ORAZIO C., OA1489,
- Page 432 and 433:
AUTHOR INDEX DEVRAJ M., PA2689 DEWA
- Page 434 and 435:
AUTHOR INDEX EL ANDALOUSSI M., PA25
- Page 436 and 437:
AUTHOR INDEX PA2634, PA2636, 3266,
- Page 438 and 439:
AUTHOR INDEX GARCIA MOYANO M., PA23
- Page 440 and 441:
AUTHOR INDEX GORHAM J., PA2820 GORI
- Page 442 and 443:
AUTHOR INDEX HANIBUCHI M., PA778 HA
- Page 444 and 445:
AUTHOR INDEX HOLMES L., PA4101, PA4
- Page 446 and 447:
AUTHOR INDEX JADDOE V., PA3134 JADH
- Page 448 and 449:
AUTHOR INDEX KANG B., PA1160, 2485
- Page 450 and 451:
AUTHOR INDEX KJELDGAARD P., PA1125,
- Page 452 and 453:
AUTHOR INDEX KUNA P., OA256, PA964,
- Page 454 and 455:
AUTHOR INDEX PA5096 LEPEJ D., PA129
- Page 456 and 457:
AUTHOR INDEX PA1311 MACEDO C., PA25
- Page 458 and 459:
AUTHOR INDEX MARTÍNEZ-MEMIJE R., P
- Page 460 and 461:
AUTHOR INDEX MIKURA S., PA4847 MILA
- Page 462 and 463:
AUTHOR INDEX MOYA A., PA3762 MOYA A
- Page 464 and 465:
AUTHOR INDEX NIKOLETOU D., PA1368 N
- Page 466 and 467:
AUTHOR INDEX PA1569 OUPADIA S., PA2
- Page 468 and 469:
AUTHOR INDEX OA1802, PA2083, PA2373
- Page 470 and 471:
AUTHOR INDEX PPATHANASSIOU E., PA41
- Page 472 and 473:
AUTHOR INDEX PA4311, PA4325 RIBEIRO
- Page 474 and 475:
AUTHOR INDEX SABOGAL PINEROS Y., PA
- Page 476 and 477:
AUTHOR INDEX SCHMIDT A., PA902 SCHM
- Page 478 and 479:
AUTHOR INDEX SIMIDCHIEV A., PA300 S
- Page 480 and 481:
AUTHOR INDEX STANCHEVA G., PA2854,
- Page 482 and 483:
AUTHOR INDEX PA4357, PA4359 TAN L.,
- Page 484 and 485:
AUTHOR INDEX TRIEBNER K., 629, OA49
- Page 486 and 487:
AUTHOR INDEX PA601, PA1825, 2903, 3
- Page 488 and 489:
AUTHOR INDEX PA3864, 4501, 4856 WAL
- Page 490 and 491:
AUTHOR INDEX YAMAMOTO A., PA569, PA